MEMULAI KEMBALI
By : MONITA TAHALEA
[intro] D G A 4x
D D/F# G F#/A# Bm
Matahari sudah di penghujung petang
Em G F# Bm E
Kulepas hari dan sebuah kisah
G F#m Em D A
Tentang angan pilu yang dahulu melingkupiku
G F#m Em A
Sejak saat itu langit senja tak lagi sama
[int] D G A 4x
D D/F# G F#/A# Bm
Sebuah janji terbentang di langit biru
Em G F# Bm E
Janji yang datang bersama pelangi
G F#m Em D A
Angan-angan pilu pun perlahan-lahan menghilang
G F#m Em A Bm
Dan kabut sendupun berganti menjadi rindu
[chorus]
G
Aku mencari
A
Aku berjalan
Bm A/C#
Aku menunggu
D G
Aku melangkah pergi
Gm A D
Kaupun tak lagi kembali
[int] G A
D D/F# G F#/A# Bm
Sebuah janji terbentang di langit biru
Em G F# Bm E
Janji yang datang bersama pelangi
G F#m Em D A
Angan-angan pilu pun perlahan-lahan menghilang
G F#m Em D A
Dan kabut sendupun berganti menjadi rindu
G F#m Em A
Sejak saat itu langit senja tak lagi sama..
[solo] G F Em F#m Bm A/C#
G F#m Em D A
Angan-angan pilu pun perlahan-lahan menghilang
G F#m Em D A
Dan kabut sendupun berganti menjadi rindu
G F#m Em A Bm
Sejak saat itu langit senja tak lagi sama..
[chorus]
G
Aku mencari
A
Aku berjalan
Bm A/C#
Aku menunggu
D G
Aku melangkah pergi
Gm A
Kaupun tak lagi
D-C#m-Bm-A G
Aku mencari
A
Aku berjalan
Bm A/C#
Aku menunggu
D G
Aku melangkah pergi
Gm A
Kaupun tak lagi
Gm A D
Dan ku tlah memulai kembali
[outro] G A D 2x
It's the Catch-22 of clinical trials: to protect pregnant women and children from the risks of untested drugs....we don't test drugs adequately for them. In the last few decades , we've been more concerned about the harms of research than of inadequately tested treatments for everyone, in fact. But for "vulnerable populations," like pregnant women and children, the default was to exclude them. And just in case any women might be, or might become, pregnant, it was often easier just to exclude us all from trials. It got so bad, that by the late 1990s, the FDA realized regulations and more for pregnant women - and women generally - had to change. The NIH (National Institutes of Health) took action too. And so few drugs had enough safety and efficacy information for children that, even in official circles, children were being called "therapeutic orphans." Action began on that, too. There is still a long way to go. But this month there was a sign that ...
Comments
Post a Comment